Lorna Duffy

This inventor holds 11 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Corcept Therapeutics Incorporated, Step Pharma S.a.s., Horizon Orphan LLC. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lorna Duffy. Retrieved from https://idiyas.com/inventor/lorna-duffy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 11)

% Patents Active = 81.8

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 40(Granted Patents)

Company Filing History:

5 out of 138

Corcept Therapeutics Incorporated

Topivert Pharma Limited

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466810 - N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases (2025-11-11),

2. 12180186 - Quaternary indazole glucocorticoid receptor antagonists (2024-12-31),

3. 12098141 - Bicyclic indazole glucocorticoid receptor antagonists (2024-09-24),

4. 12018001 - Pyrimidine cyclohexenyl glucocorticoid receptor modulators (2024-06-25),

5. 11787780 - Quaternary indazole glucocorticoid receptor antagonists (2023-10-17),

6. 11655246 - Aminothiazole compounds as inhibitors of CTPS1 (2023-05-23),

7. 11542238 - Pyrimidine cyclohexenyl glucocorticoid receptor modulators (2023-01-03),

8. 11505550 - ADO-resistant cysteamine analogs and uses thereof (2022-11-22),

9. 11505547 - Compounds (2022-11-22),

10. 10906904 - ADO-resistant cysteamine analogs and uses thereof (2021-02-02),

11. 9249125 - Pyrazole derivatives as p38 MAP inhibitors (2016-02-02),

Title: Lorna Duffy: Pioneering Innovations in Nottingham

Introduction: Lorna Duffy, a renowned inventor hailing from Nottingham, GB, has made significant contributions to the world of innovation. With a portfolio comprising 7 patents, Duffy's work delves into cutting-edge advancements in various fields.

Latest Patents:

1. Quaternary Indazole Glucocorticoid Receptor Antagonists: Duffy's patent discloses compounds that can modulate glucocorticoid receptors, offering potential in pharmaceutical formulations.

2. Aminothiazole Compounds as Inhibitors of CTPS1: Another groundbreaking patent by Duffy introduces compounds that inhibit CTPS1, showcasing his expertise in medicinal chemistry.

Career Highlights: Duffy has showcased his talent at esteemed companies such as Corcept Therapeutics Incorporated and Horizon Orphan LLC. His innovative spirit has driven these organizations forward, solidifying his reputation as a visionary inventor.

Collaborations: Throughout his career, Duffy has collaborated with notable peers such as Hazel Joan Hunt and Todd C. Zankel, enriching his projects with diverse perspectives and expertise.

Conclusion: Lorna Duffy emerges as a trailblazer in the realm of innovation, weaving together science and creativity to shape a brighter future. His relentless pursuit of technological advancement continues to inspire inventors and entrepreneurs globally, leaving an indelible mark on the landscape of innovation.

Profile summary based on public USPTO records.